SEC Form 4 · accession 0001209191-15-070097
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lynch
Director
Period of report
Sep 8, 2015
Accepted (ET)
Sep 10, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2015 | M | 7,000 | $2.0864 | A | 7,000 | D | |
| Common StockF2 | Sep 8, 2015 | S | 500 | $130.679 | D | 6,500 | D | |
| Common StockF3 | Sep 8, 2015 | S | 2,550 | $131.4486 | D | 3,950 | D | |
| Common StockF4 | Sep 8, 2015 | S | 600 | $132.2183 | D | 3,350 | D | |
| Common StockF5 | Sep 8, 2015 | S | 1,300 | $133.6437 | D | 2,050 | D | |
| Common StockF6 | Sep 8, 2015 | S | 2,050 | $134.4642 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $2.0864 | Sep 8, 2015 | M | 7,000 | D | — | Jul 13, 2021 | Common Stock | 7,000 | 29,008 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2015.
- F2The range of prices for the transaction reported on this line was $130.00 to $130.95. The average weighted price was $130.6790. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $131.04 to $131.95. The average weighted price was $131.4486. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $132.14 to $132.40. The average weighted price was $132.2183. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $133.16 to $134.14. The average weighted price was $133.6437. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $134.165 to $135.00. The average weighted price was $134.4642. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011